Bridgewater, MA -- (SBWIRE) -- 04/03/2013 -- The Automated StockConsultant screener has found provider of therapeutics that improves cancer treatment options Dendreon Corporation (NASDAQ:DNDN) stock at strong support with an upside target of 6.
DNDN stock price is down 3.7% to 4.62 today but still remains in the strong triple+ support area centered at 4.62 and at an oversold condition. The stock has excellent upside trade quality with a target price of 6 for a short-term gain of 29.9%.
Read the full StockConsultant Report on DNDN
StockConsultant.com provides automated stock consulting reports and an advanced screener on over 6000 US equities. Each detailed stock report contains easy to use technical analysis indicators, charts, and news to fine tune stock entry and exit price levels. A daily "Stocks to Watch" list, real-time portfolio (show up to 35 stock charts simultaneously) and keyboard controlled QuickCharts complete the tools.
Disclosure: StockConsultant.com and its employees are not registered investment advisors and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Please check with a registered investment advisor before making any investment decisions. For our full disclaimer please visit www.stockconsultant.com/disclaimerpage.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)